Welcome to our dedicated page for UBS ETRACS Alerian MLP Index ETN Series B SEC filings (Ticker: AMUB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AMUB filings document UBS AG’s role as the foreign private issuer behind the ETRACS Alerian MLP Index ETN Series B and the broader debt-securities platform under which UBS offers registered securities. UBS AG’s Form 6-K materials include quarterly and annual reporting references, IFRS financial information, capitalization tables, debt issued, registration-statement updates, legal opinions and offering-related disclosures.
The filing record also covers UBS Group and UBS AG risk and capital management, Pillar 3 regulatory capital metrics, leverage, liquidity and funding, governance signatures, and material reports involving debt securities. These disclosures frame AMUB as a senior unsecured UBS AG obligation whose value and payments depend on the note terms and UBS AG credit risk.
UBS AG is offering $5,424,000 of Trigger Jump Securities with an auto‑call feature tied to the worst‑performing of the S&P 500 (initial level 6,552.51) and Russell 2000 (initial level 2,394.595), maturing on October 16, 2031.
The notes pay no interest. On any determination date before maturity, if both indices close at or above their initial levels, the notes are automatically redeemed at $1,000 plus a premium that steps up based on ~8.30% per annum. If held to maturity and both indices finish at or above initial, investors receive $1,498.00 per $1,000. If any index finishes below initial but both remain at or above 80% of initial (5,242.01 for the S&P 500; 1,915.676 for the Russell 2000), investors receive $1,000. If any index finishes below its 80% downside threshold, repayment is reduced one‑for‑one with the worst performer and can be zero.
Issue price is $1,000 per note; total fees are 3.50% (3.00% sales, 0.50% structuring), with proceeds to UBS of 96.50%. The estimated initial value is $950.10. The notes are unsecured obligations of UBS AG, will not be listed, and are subject to UBS credit risk.
UBS AG is offering $1,985,000 of Trigger Autocallable Contingent Yield Notes linked to Meta Platforms common stock, maturing on October 19, 2028. The notes pay a 13.15% per annum contingent coupon only when META’s closing level on a quarterly observation date is at or above the coupon barrier of $496.06 (70% of the initial level).
The notes are automatically called if META is at or above the call threshold of $708.65 (100% of the initial level) on any observation date before final maturity, returning principal plus the applicable coupon. If not called, and META’s final level is at or above $496.06, holders receive principal at maturity. If the final level is below $496.06, the maturity payment is reduced one-for-one with META’s decline, and investors could lose all principal.
Issue price is $1,000 per note; estimated initial value is $973.00. Underwriting discount is $20.00 per note, for proceeds to UBS of $980.00 per note. Payments depend on UBS’s credit. The notes will not be listed.
UBS AG plans to offer Trigger Callable Contingent Yield Notes linked to the least performing of the Dow Jones Industrial Average, Nasdaq‑100, and Russell 2000. The Notes pay a contingent coupon only if each index closes at or above its coupon barrier on the monthly observation date; otherwise no coupon is paid. UBS may call the Notes, in whole, on any observation date beginning after 3 months, returning principal plus any due coupon. If not called and each index finishes at or above its downside threshold at maturity, investors receive principal back.
If any index finishes below its downside threshold at maturity, the repayment is reduced by that index’s percentage decline, up to total loss of principal. Key terms include a contingent coupon rate of 10.75% per annum, coupon barriers and downside thresholds at 70.00% of initial levels, monthly observations, expected trade date October 24, 2025, and maturity on or about October 28, 2027. Issue price is $1,000 per Note, with an underwriting discount of $6.50 and proceeds to UBS of $993.50 per Note. The estimated initial value is expected between $961.50 and $991.50, and payments are subject to UBS credit risk.
UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Moderna, Inc., due October 14, 2026. The notes pay a contingent coupon only if the underlying closes on each observation date at or above a coupon barrier; otherwise no coupon is paid. The notes will be automatically called if the underlying closes at or above the initial level on any observation date before the final valuation date, returning principal plus any due coupon.
If not called, and the final level is at or above the downside threshold, investors receive principal at maturity; if below, repayment is reduced one-for-one with the underlying’s decline, and investors could lose all principal. Payments are subject to UBS credit risk. Key dates: trade date October 9, 2025, settlement October 14, 2025, final valuation October 12, 2026, maturity October 14, 2026. The notes are offered at $10 per Note (minimum 100 Notes) and have an estimated initial value of $9.81. The notes will not be listed.
UBS AG is offering $500,000 Trigger Autocallable Contingent Yield Notes linked to Intel Corporation common stock, due October 19, 2026. These unsecured, unsubordinated notes pay a contingent coupon only when Intel’s closing level on an observation date is at or above the coupon barrier.
The contingent coupon rate is 18.72% per annum, equating to $0.468 per quarter per $10 note when payable. The notes auto-call if Intel’s level on an observation date (before the final valuation date) is at or above the initial level; if called, investors receive principal plus the applicable contingent coupon.
If not called, principal is repaid at maturity only if the final level is at or above the downside threshold. The coupon barrier and downside threshold are $22.29, which is 60.00% of the initial level. If the final level is below the downside threshold, repayment is reduced one-for-one with Intel’s decline, up to total loss. The estimated initial value is $9.79 per $10 note. The notes are not listed and are subject to UBS credit risk.
UBS AG filed a preliminary 424(b)(2) pricing supplement for Trigger Autocallable Contingent Yield Notes linked to Broadcom Inc. common stock. The Notes pay a contingent coupon only if the stock closes at or above a coupon barrier on observation dates, and they may be automatically called early if the stock is at or above the initial level on any observation date before maturity.
If not called, principal is repaid at maturity only if the final level is at or above a downside threshold; otherwise, repayment falls with the stock’s decline and can reach zero. Key dates include an expected trade date of October 15, 2025, settlement on October 17, 2025, final valuation on October 14, 2027, and maturity on October 18, 2027. The estimated initial value per $10 Note is expected to be between $9.52 and $9.77. The minimum investment is 100 Notes at $10 each. Payments are unsecured obligations of UBS and the Notes will not be listed on an exchange.
UBS AG filed a 424B2 for $3,873,000 Trigger Callable Contingent Yield Notes linked to the least performing of the Dow Jones Industrial Average, Nasdaq-100 Technology Sector Index, and Russell 2000 Index, due July 18, 2030. The Notes pay a 9.25% per annum contingent coupon only if each index closes at or above its coupon barrier on monthly observation dates; otherwise no coupon is paid. UBS may call the Notes in whole on any observation date beginning after 6 months, returning principal plus any due coupon.
If not called, principal is repaid at maturity only if each index’s final level is at or above its downside threshold; if any index finishes below its threshold, repayment is reduced one-for-one with the loss of the worst index, up to total loss of principal. Initial levels/barriers/thresholds: INDU 46,270.46 / 70% / 60%; NDXT 12,574.97 / 70% / 60%; RTY 2,495.499 / 70% / 60%. The estimated initial value is $978.60 per $1,000 note. Key dates: trade Oct 14, 2025, settlement Oct 17, 2025, final valuation July 15, 2030. The Notes are unsecured obligations of UBS, will not be listed, and payments depend on UBS’s credit.
UBS AG is offering $1,215,000 of Trigger Autocallable Contingent Yield Notes linked to Microsoft common stock, due October 19, 2028.
The Notes pay a 9.85% per annum contingent coupon ($24.625 per quarter per $1,000) only if MSFT’s closing level on an observation date is at or above the coupon barrier $410.86 (80% of the initial level). The Notes are automatically called if MSFT closes at or above the call threshold $513.57 (100% of the initial level) on any observation date before maturity, returning principal plus the applicable coupon.
If not called, and the final level is at or above $410.86, principal is repaid at maturity. If the final level is below the downside threshold, repayment equals $1,000 × (1 + underlying return), exposing investors to losses up to total principal. Payments are subject to the creditworthiness of UBS; the Notes will not be listed.
Issue price is $1,000 per Note; the estimated initial value is $973.20 per Note. Underwriting discount is $20 per Note; proceeds to UBS total $1,190,700. Observation dates are quarterly through maturity.
UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Moderna, Inc., maturing on October 13, 2026. These unsecured, unsubordinated notes pay a contingent coupon only when the underlying stock closes at or above a preset coupon barrier on an observation date. The notes may be called early if the stock closes at or above the initial level on any observation date before the final valuation date, returning principal plus the due coupon for that period.
If not called, and the stock is at or above the downside threshold on the final valuation date, investors receive principal back; if it is below the downside threshold, repayment is reduced one-for-one with the stock’s decline, and total loss is possible. Any payment is subject to UBS’s credit.
Key terms include trade date October 8, 2025, settlement October 10, 2025, final valuation date October 9, 2026, and minimum investment of 100 notes at $10 per note. The estimated initial value is $9.76 per note. The notes will not be listed on any exchange.
UBS AG launched an amended preliminary pricing supplement for Trigger Autocallable Contingent Yield Notes linked to the common stock of Moderna, Inc., maturing on or about October 13, 2026. These unsecured, unsubordinated notes pay a contingent coupon only if the underlying closes at or above a coupon barrier on an observation date. The notes are automatically called if the underlying closes at or above the initial level on any observation date before final valuation; in that case, investors receive principal plus the applicable coupon and the notes terminate.
If not called, and the final level is at or above the downside threshold, investors receive principal at maturity (and the final coupon if the barrier is met). If the final level is below the downside threshold, repayment is reduced one-for-one with the underlying’s decline, and investors could lose their entire investment. All payments are subject to the creditworthiness of UBS.
Key terms: trade date October 8, 2025; settlement October 10, 2025; final valuation October 9, 2026; maturity October 13, 2026. Minimum investment is 100 Notes at $10 per Note. The estimated initial value per Note is expected between $9.57 and $9.82. The notes will not be listed on an exchange.